Alerts will be sent to your verified email
Verify Email
NGLFINE
|
NGL Fine-Chem
|
Sequent Scientific
|
Themis Medicare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.68 % | -0.13 % | 15.48 % |
|
5yr Avg Net Profit Margin
|
12.56 % | 0.03 % | 13.75 % |
|
Price to Book
|
3.17 | 6.05 | 2.29 |
|
P/E
|
42.94 | 143.64 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
24.74 Days | 49.09 Days | 62.99 Days |
|
5yr Average Interest Coverage Ratio
|
25.7 | 1.93 | 7.27 |
|
5yr Avg ROCE
|
24.83 % | 6.67 % | 17.31 % |
|
5yr Avg Operating Profit Margin
|
18.08 % | 7.74 % | 18.07 % |
|
5 yr average Debt to Equity
|
0.16 | 0.53 | 0.28 |
|
5yr CAGR Net Profit
|
-18.08 % | -25.52 % | -3.53 % |
|
5yr Average Return on Assets
|
13.76 % | 0.05 % | 9.9 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.74 % | 52.61 % | 67.15 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 2.43 % |
|
Change in Promoter Holding (3 Yrs)
|
-1.07 % | -0.18 % | -0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 9.79 % | 0.0 |
|
NGL Fine-Chem
|
Sequent Scientific
|
Themis Medicare
|
|---|